{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "Y1699C",
        "Protein_Change": {
          "ref": "L858",
          "alt": "R1441",
          "position": "858"
        },
        "variant_string_id": "EGFR Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Y1699C mutation enhances stress tolerance in HEK293 and SH-SY5Y cells, linked to ERK pathway activation.",
          "judgment": "Yes",
          "reasoning": "The paper directly links the mutation to its functional impact in cellular stress response pathways."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Basic controls were included (wild-type and mutant cells), with multiple replicates used.",
          "judgment": "Yes",
          "reasoning": "The functional evidence is supported by established methods and experimental repetition."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Statistical analysis was performed, indicating sufficient data for OddsPath calculation.",
          "judgment": "Yes",
          "reasoning": "The results align with known pathogenicity thresholds."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath > 2.0 indicates PS3_supporting.",
          "judgment": "Yes",
          "reasoning": "The strength is consistent with pathogenicity in cellular stress response mechanisms."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "Both Y1699C and G2019S mutations are pathogenic, supported by functional evidence in cellular stress resistance and ERK pathway activation."
    },
    {
      "variant_id": {
        "Gene": "G2019S",
        "Protein_Change": {
          "ref": "R1441",
          "alt": "R1441",
          "position": "1441"
        },
        "variant_string_id": "CFTR G2019S"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "G2019S mutation causes loss of cell viability in SHSY5Y cells, linked to oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The mutation directly links to its effect on cellular vulnerability."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Basic controls were included, with multiple replicates used.",
          "judgment": "Yes",
          "reasoning": "The functional evidence is supported by established methods and experimental repetition."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "OddsPath > 2.0 indicates PS3_supporting.",
          "judgment": "Yes",
          "reasoning": "The strength is consistent with benignity in cellular stress resistance."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath > 2.0 indicates PS3_supporting.",
          "judgment": "Yes",
          "reasoning": "The strength is consistent with benignity in cellular stress resistance."
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_very_strong"
      },
      "overall_conclusion": "Both G2019S and Y1699C mutations are benign, supported by functional evidence in cellular stress resistance and ERK pathway activation."
    }
  ]
}